The lymph node ratio optimises staging in patients with node positive colon cancer with implications for adjuvant chemotherapy
- 20 March 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Colorectal Disease
- Vol. 29 (5), 599-604
- https://doi.org/10.1007/s00384-014-1848-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ratio of Metastatic To Resected Lymph Nodes Enhances To Predict Survival In Patients With Stage III Colorectal CancerAnnals of Surgical Oncology, 2011
- Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2010
- The Prognostic Value of Lymph Node Ratio in a Population-Based Collective of Colorectal Cancer PatientsAnnals of Surgery, 2010
- Ratio of Metastatic to Resected Lymph Nodes as a Prognostic Factor in Node-Positive Colorectal CancerAnnals of Surgical Oncology, 2010
- Positive lymph node retrieval ratio optimises patient staging in colorectal cancerBritish Journal of Cancer, 2009
- Should Total Number of Lymph Nodes be Used as a Quality of Care Measure for Stage III Colon Cancer?Annals of Surgery, 2009
- Lymph Node Evaluation and Long-Term Survival in Stage II and Stage III Colon Cancer: A National StudyAnnals of Surgical Oncology, 2008
- The number of analyzed lymph nodes – a prognostic factor in colorectal cancerActa Oncologica, 2007
- Colon Cancer Survival Is Associated With Decreasing Ratio of Metastatic to Examined Lymph NodesJournal of Clinical Oncology, 2005
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995